Cargando…
Genome-wide association study identifies two loci influencing plasma neurofilament light levels
BACKGROUND: Plasma neurofilament light (NFL) is a promising biomarker for Alzheimer disease (AD), which increases in the early stage of AD and is associated with the progression of AD. We performed a genome-wide association study (GWAS) of plasma NFL in Alzheimer’s Disease Neuroimaging Initiative 1...
Autores principales: | Li, Jie-Qiong, Yuan, Xiang-Zhen, Li, Hai-Yan, Cao, Xi-Peng, Yu, Jin-Tai, Tan, Lan, Chen, Wei-An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946407/ https://www.ncbi.nlm.nih.gov/pubmed/29747637 http://dx.doi.org/10.1186/s12920-018-0364-8 |
Ejemplares similares
-
Genome-wide association study identifies CD1A associated with rate of increase in plasma neurofilament light in non-demented elders
por: Wang, Zuo-Teng, et al.
Publicado: (2019) -
Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults
por: Hu, Hao, et al.
Publicado: (2019) -
Neurofilament light chain level in plasma extracellular vesicles and
Parkinson’s disease
por: Chung, Chen-Chih, et al.
Publicado: (2020) -
Comparing Neurofilament Light Chain Levels in Serum and Plasma
por: Kwon, Hyuk Sung, et al.
Publicado: (2023) -
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
por: Mattsson, Niklas, et al.
Publicado: (2017)